Please assess the completion status of the following clinical trial:

Trial Title: A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Signed patient informed consent~2. Shallow osteochondral defect ≤ 12 mm diameter and ≤ 8 mm depth in weight bearing area~3. Agree to actively participate in a rehabilitation protocol~Exclusion Criteria:~1. Severe vascular or neurological disease~2. Uncontrolled diabetes~3. Severe degenerative joint disease~4. Pregnancy~5. Presence of infection at the site or in the joint space (e.g. osteomyelitis)~6. Diagnosis rheumatoidism~7. Advanced osteoarthritis as judged by the surgeon~8. Drug and/or alcohol abuse~9. Hypercalcemia~10. Known allergy to any of the components of the device (e.g. bovine collagen)~11. Bleeding disorders of any etiology~12. Steroidal or immunosuppressive maintenance therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Osteochondral lesions (Type: None): Patients with osteochondral lesions in the knee, the ankle, or other joint

Based on this trial design, predict the completion outcome and termination type (if applicable).